Table 7.
Baseline characteristics and reduced clinical characteristics 6 months after surgery: differences between diabetic and non-diabetic patients.
| Diabetic | Non-diabetic | p | |
|---|---|---|---|
| n = 39 | n = 68 | ||
| Age (y) | 39.28 ± 7.31 | 35.56 ± 1.48 | 0.003 |
| SBP (mmHg) | 127.00 ± 13.62 | 123.91 ± 9.69 | 0.22 |
| ΔSBP | 0.00 (0.00,10.00) | 0.00 (0.00,1.75) | 0.29 |
| BMI (kg/m2) | 38.72 ± 7.10 | 39.39 ± 5.42 | 0.61 |
| ΔBMI | 9.26 ± 3.66 | 10.70 ± 3.20 | 0.036 |
| TC (mmol/l) | 4.76 ± 0.98 | 4.73 ± 0.83 | 0.87 |
| ΔTC | 0.53 (−0.09,1.03) | 0.03 (−0.41,0.55) | 0.02 |
| HbA1c | 7.53 ± 1.68 | 5.59 ± 0.45 | 0.001 |
| ΔHbA1c | 1.65 (0.87,3.05) | 0.50 (0.20,0.70) | <0.001 |
| ICVD total score | 5.00 (4.00,6.00) | 2.00 (2.00,3.00) | <0.001 |
| ΔICVD total score | 0.53 (−0.09,1.03) | 1.00 (0.00,2.00) | 0.88 |
SBP, systolic blood pressure; ΔSBP, reduction in systolic blood pressure 6 months after surgery; BMI, body mass index; ΔBMI, reduction in body mass index 6 months after surgery; TC, total cholesterol; ΔTC, reduction in total cholesterol 6 months after surgery; HbA1c, glycosylated hemoglobin; ΔHbA1c, reduction in glycosylated hemoglobin 6 months after surgery; ICVD, ischemic cardiovascular disease; ΔICVD, reduction in ischemic cardiovascular disease 6 months after surgery.